SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008187
Filing Date
2018-11-01
Accepted
2018-10-31 18:21:56
Documents
71
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20180930x10q.htm 10-Q 2151123
2 EX-31.1 clvs-20180930ex3112214d3.htm EX-31.1 19894
3 EX-31.2 clvs-20180930ex31248b73d.htm EX-31.2 20129
4 EX-32.1 clvs-20180930ex321689237.htm EX-32.1 8008
5 EX-32.2 clvs-20180930ex3224ad3ad.htm EX-32.2 8384
  Complete submission text file 0001558370-18-008187.txt   8457136

Data Files

Seq Description Document Type Size
6 EX-101.INS clvs-20180930.xml EX-101.INS 2122776
7 EX-101.SCH clvs-20180930.xsd EX-101.SCH 44575
8 EX-101.CAL clvs-20180930_cal.xml EX-101.CAL 62661
9 EX-101.DEF clvs-20180930_def.xml EX-101.DEF 149513
10 EX-101.LAB clvs-20180930_lab.xml EX-101.LAB 460332
11 EX-101.PRE clvs-20180930_pre.xml EX-101.PRE 320301
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 181151352
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences